Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI. - Wikidata - wikimedia - TriplyDB

Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI.

Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI.

http://www.wikidata.org/entity/Q39935921

about

Phase IIb randomized trial of adjunct immunotherapy in patients with first-diagnosed tuberculosis, relapsed and multi-drug-resistant (MDR) TB Immunotherapy for tuberculosis: future prospects Recent advances in the development of vaccines for tuberculosis Vaccine development for tuberculosis: current progress Vaccines for TB: Lessons from the Past Translating into Future Potentials The Progress of Therapeutic Vaccination with Regard to Tuberculosis The ongoing challenge of latent tuberculosis Prophylactic effect of a therapeutic vaccine against TB based on fragments of Mycobacterium tuberculosis Toward novel vaccines against tuberculosis: current hopes and obstacles.Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial Vaccine against tuberculosis: what's new?Safety, tolerability, and immunogenicity of the novel antituberculous vaccine RUTI: randomized, placebo-controlled phase II clinical trial in patients with latent tuberculosis infection.Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis Vaccines Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies.Current and novel approaches to vaccine development against tuberculosis.Advances in the Diagnosis, Treatment and Control of HIV Associated Tuberculosis Evaluation of the overall IFN-γ and IL-17 pro-inflammatory responses after DNA therapy of tuberculosis.The impact of transcriptomics on the fight against tuberculosis: focus on biomarkers, BCG vaccination, and immunotherapy.Tuberculosis vaccines in clinical trials.Immunity to TB and targets for immunotherapy.Immune approaches in tuberculosis therapy: a brief overview.Immunotherapy for TB.Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines.Totally drug-resistant tuberculosis and adjunct therapies.An overview of tuberculosis plant-derived vaccines.Global Efforts in the Development of Vaccines for Tuberculosis: Requirements for Improved Vaccines Against Mycobacterium tuberculosis.Successes and failures in human tuberculosis vaccine development.Adjunct immune therapy of first-diagnosed TB, relapsed TB, treatment-failed TB, multidrug-resistant TB and TB/HIV.Adjunct oral immunotherapy in patients with re-treated, multidrug-resistant or HIV-coinfected TB.GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis.The current status, challenges, and future developments of new tuberculosis vaccines.Impfung gegen Tuberkulose Recent developments in tuberculosis vaccines

P2860

Q21245662-BE755A81-C39B-4F57-BB56-EE32DFF7C6B0 Q26741261-918D40B9-EBD5-4D9F-9B41-2466D588F4CB Q26796440-D5B280FE-22A1-4141-988D-7C3760B183BF Q26827737-6D2738D1-B6F0-4A15-9DE1-B3E588339668 Q26996673-AB2EE8CD-E643-4B20-B72C-EB1DEC801627 Q28072271-22FC8C95-1BD7-4ADA-B438-E5F875953E95 Q28386135-3CA70655-1DC0-462E-8623-820E71A5212F Q28744312-6AA2AD94-2E25-481C-A596-81CA65044D5E Q30484783-F360102F-E483-4936-A199-000A74EA59CB Q33793948-DC698CF6-79F7-4AB9-BAEE-B9D714E2B9AD Q35101472-6120730D-121C-4479-8EDE-E4A5101D63DA Q35107731-95F0BA13-949B-4333-99D1-F0D906461033 Q35772893-98B24828-D069-4319-A967-B333FC284219 Q36238015-EFFFF589-AC1D-4C94-9C1A-7C789BFA10E0 Q36449189-E9108F8C-D2D4-4B04-A9DC-47C12EF68B50 Q36627619-593C7D09-93EB-4EB6-AB6C-2F9900512731 Q37505396-506AC92D-78E3-40A8-97E5-C1292C77B725 Q37825430-483D58E0-F630-4071-BF50-EA2E896D8A8F Q37878483-FA8267AB-433F-4337-A5B8-CAF2EF5E22BF Q37984571-185E70C5-5F96-477F-B63C-32ED3343FE82 Q37991393-C93C1A66-59B5-4E8A-944E-2932E2E64DB5 Q38025666-7DA797D1-4458-4CF7-B87C-C98560529B72 Q38059150-BA174514-9700-4A3E-A7FF-224D29C40E08 Q38210265-5B31C5D5-D247-4EFE-A95A-9E673A2B3B66 Q38356275-56E4264C-270C-4304-A8F4-AB447AC3F683 Q38907507-BDF197FC-847A-40C2-9ABC-DCE62C7B0E35 Q41996442-00070569-EE81-464A-B8D7-0DB3354B1514 Q44579437-3DA849C9-A0E9-4B2B-99D8-3FF07D15B417 Q44736504-E7907CAD-922E-4F49-9A10-76ECD2DE5975 Q46310148-EFA6621D-2A7D-4961-BAFA-79859541EE93 Q52337140-8F1D1E59-6FA5-4371-A588-7052C06C3C63 Q57598511-F473DCA0-3CDD-4F71-A3DC-238D26B7664D Q58834925-16471D00-41AA-4A47-9A6B-003B245DC048

P2860

Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI.

http://www.wikidata.org/entity/Q39935921

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Double-blind, randomized, plac ...... antituberculous vaccine RUTI.

@en

Double-blind, randomized, plac ...... antituberculous vaccine RUTI.

@nl

type

label

Double-blind, randomized, plac ...... antituberculous vaccine RUTI.

@en

Double-blind, randomized, plac ...... antituberculous vaccine RUTI.

@nl

prefLabel

Double-blind, randomized, plac ...... antituberculous vaccine RUTI.

@en

Double-blind, randomized, plac ...... antituberculous vaccine RUTI.

@nl

P1433

Q39935921-008A17A9-680D-4120-89E0-22E9DA616EC6

P1476

Q39935921-663DA12E-862B-4310-B79E-E862981642F9

P2093

Q39935921-2BD5F009-7B79-4691-83F4-44F56BB90E22

Q39935921-A5F77DC9-E663-4099-80AC-8C6D90452DD0

Q39935921-D72E0415-BEDD-4267-A9D8-6A3C40173ACC

Q39935921-DA33BECD-E8D6-4913-AC4B-912F4597FFB2

Q39935921-DA871F1C-0E05-41BC-8C86-94A7696E3D61

P304

Q39935921-1588185C-B102-4FF9-9BA9-DDC0E59307E6

P31

Q39935921-74E904A6-70D0-4644-A2EB-1A2B6723523B

P356

Q39935921-9ED7C5E6-7EDC-4B1E-A221-6877E669AC98

P407

Q39935921-D64F3253-E2B1-4C12-8465-4C125588B54E

P433

Q39935921-C737C6EE-45EF-4BBD-BDB5-B0E7F22D9CA3

P478

Q39935921-1CF447DA-C2FF-4B07-B86D-F33405DD2833

P50

Q39935921-5DC7FC83-951B-4F9E-A69F-B41D19EEC82C

Q39935921-8774CCA5-CAD8-4CE6-BE62-9E5BDB401387

Q39935921-A64EF2A1-6C70-44E0-9117-C69AD994CEEF

P577

Q39935921-261A8FFE-78E3-4C76-A0F4-759AFF53D513

P5875

Q39935921-D66E385B-0031-4BD3-AEF9-3F4E35669007

P698

Q39935921-CE1E6613-DB64-48D0-B398-B63FAD46BE1F

P921

Q39935921-2114DF53-0316-4942-B938-BB46F9CE26A8

Q39935921-C87D06B4-88B0-4ED9-B50E-A12EC120D35B

P356

J.VACCINE.2009.09.134

P1433

P1476

Double-blind, randomized, plac ...... antituberculous vaccine RUTI.

@en

P2093

A M Barriocanal

http://www.w3.org/2001/XMLSchema#string

G Domenech

http://www.w3.org/2001/XMLSchema#string

Joan Costa

http://www.w3.org/2001/XMLSchema#string

P J Cardona

http://www.w3.org/2001/XMLSchema#string

S Pinto

http://www.w3.org/2001/XMLSchema#string

P304

1106-1116

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2009.09.134

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Cristina Vilaplana

P577

2009-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38033144

http://www.w3.org/2001/XMLSchema#string

P698

19853680

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial